CUE-101
CUE-101-01
Phase 1 small_molecule completed
Quick answer
CUE-101 for Head and Neck Cancer is a Phase 1 program (small_molecule) at Cue Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cue Biopharma
- Indication
- Head and Neck Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed